What are the differential diagnoses for conditions that can mimic polypoidal choroidal vasculopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis of Polypoidal Choroidal Vasculopathy

The key conditions that mimic polypoidal choroidal vasculopathy (PCV) include neovascular age-related macular degeneration (nAMD), central serous chorioretinopathy (CSC), pachychoroid neovasculopathy, and other causes of subretinal neovascularization—each distinguished by specific imaging findings and patient demographics.

Primary Differential Diagnoses

Neovascular Age-Related Macular Degeneration (nAMD)

  • Key distinguishing features: Presence of drusen, typically in older patients 11
  • Imaging: Neovascular lesions visible on OCT, OCT-A, FA, and ICGA 1
  • Choroidal characteristics: Thinner choroid compared to PCV; PCV demonstrates significantly greater subfoveal choroidal thickness than nAMD 2
  • Critical pitfall: PCV can present with concurrent non-polypoidal neovascularization, making differentiation challenging 11
  • The absence of polypoidal dilatations on ICGA and OCT is the definitive differentiator 11

Central Serous Chorioretinopathy (CSC)

  • Clinical overlap: Both conditions can present with serous retinal detachments and RPE changes 3
  • Key differentiators:
    • CSC shows focal leakage on FA without polypoidal structures 3
    • Mid-phase hyperfluorescent placoid areas on ICGA in CSC versus polypoidal lesions in PCV 1
    • PCV typically occurs in older patients, while CSC affects younger to middle-aged individuals 3
  • Critical diagnostic point: In CSC with persistent/recurrent exudation, multiple RPE changes can evolve that closely mimic PCV—ICGA is essential for differentiation 3
  • Common misdiagnosis scenario: Multiple variably-sized serous PEDs in PCV can masquerade as CSC 3

Pachychoroid Neovasculopathy (PNV)

  • Distinguishing features: Neovascular network over areas of choroidal thickening and thickened Haller's layer vessels ("pachyvessels") 11
  • Imaging: Neovascular network visible on ICGA, FA, and OCT-A 1
  • Choroidal comparison: PNV demonstrates even greater choroidal thickness than PCV 2
  • Treatment overlap: Both respond to anti-VEGF and/or photodynamic therapy 1

Secondary Differential Diagnoses

Other Neovascular Conditions

High Myopia with CNV 11:

  • Chorioretinal atrophy adjacent to optic disc
  • Oblique optic disc insertion
  • Thin choroid (opposite of PCV's thick choroid)

Angioid Streaks 11:

  • Deep retinal red-brown bands
  • Often bilateral with early onset
  • Associated with pseudoxanthoma elasticum
  • Optic disc drusen present

Multifocal Choroiditis 11:

  • Yellow-white punched-out round spots deep to retina
  • Predominantly affects women under 50 years

Choroidal Rupture 11:

  • Yellow-white subretinal streak
  • History of blunt ocular trauma

Vitelliform Lesions

Best Vitelliform Macular Dystrophy 1:

  • Positive family history, bilateral symmetrical disease
  • Hyperautofluorescence on FAF
  • No focal leakage on FA, no choroidal hyperpermeability on ICGA
  • Absent/markedly decreased light rise on electro-oculography

Adult-Onset Foveomacular Vitelliform Dystrophy 1:

  • Small (<1 disc diameter) round foveal yellowish subretinal lesions
  • Central hypofluorescence with hyperfluorescent ring on FA

Diagnostic Algorithm

Step 1: Clinical Assessment

  • Age and ethnicity (PCV more common in elderly Asians) 45
  • Fundoscopic examination for orange polyp-like structures (hallmark of PCV) 6
  • Look for "serosanguineous retinopathy" pattern 6

Step 2: Essential Imaging

  • ICGA is the gold standard for identifying polypoidal dilatations 114
  • OCT to assess for polypoidal lesions, branching vascular network, and subfoveal choroidal thickness 14
  • OCT-A for neovascular network visualization 4
  • FA to evaluate leakage patterns and exclude other diagnoses 1

Step 3: Key Differentiating Features

  • Presence of polypoidal dilatations on ICGA/OCT = PCV 11
  • Drusen + neovascularization without polyps = nAMD 1
  • Focal leakage without polyps + younger age = CSC 3
  • Thick choroid with pachyvessels but no polyps = PNV 1

Critical Clinical Pearls

  • The subretinal polyp-like structure has the highest odds ratio (28) for PCV diagnosis 6
  • Scar formation has an odds ratio of 0 for PCV, making it a negative predictor 6
  • PCV can present simultaneously with CNM, requiring careful multimodal imaging 7
  • Without ICGA, PCV is frequently misdiagnosed as CSC or nAMD 38
  • Subfoveal choroidal thickness in PCV is intermediate: greater than nAMD and healthy controls, but less than CSC and PNV 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.